Scientists and instrument manufacturers gather in Philadelphia for Pittcon 2013.
The Pittcon 2013 Exposition, which takes place March 17-21 at the Pennsylvania Convention Center in Philadelphia, features emerging analytical technologies for analytical chemistry, drug discovery and development, nanotechnology, life sciences, and other disciplines. Instrument manufacturers frequently introduce new products or announce updates to current technologies at the event.
The exposition floor includes 1,926 booths and 18 seminar rooms, hosting 1,011 exhibitors (as of March 1, 2013) displaying products and services used by the scientific community in industrial, academic, and government labs. A mini-museum display of instrumentation, presented by the Chemical Heritage Foundation, celebrates the 100th anniversary of mass spectrometry.
The conference program features workshops, symposia, and short courses on chromatography, molecular and atomic spectroscopy, electrochemistry, mass spectrometry, and lab-on-chip technology.
Waters Corp. Updates Instruments and Software
Shimadzu Scientific Instruments Adds Chromatography Instruments and Software
Thermo Fisher Scientific Introduces Software, Instruments, and Consumables
Mettler Toledo Introduces Mechanical Analyzer
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.